REARDON ANDREW (CLO & Secretary) sold 10.7% of their position (5K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.44M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5K
Price / share
$52.27
Trade value
$261.35K
% of position
Common Stock
Shares
−105.00
Price / share
$284.14
Trade value
$29.83K
% of position
Common Stock
Shares
−33.00
Price / share
$284.55
Trade value
$9.39K
% of position
Common Stock
Shares
−157.00
Price / share
$285.74
Trade value
$44.86K
% of position
Common Stock
Shares
−1.03K
Price / share
$286.80
Trade value
$295.97K
% of position
Common Stock
Shares
−1.21K
Price / share
$287.77
Trade value
$349.36K
% of position
Common Stock
Shares
−356.00
Price / share
$288.75
Trade value
$102.79K
% of position
Common Stock
Shares
−503.00
Price / share
$289.80
Trade value
$145.77K
% of position
Common Stock
Shares
−200.00
Price / share
$290.60
Trade value
$58.12K
% of position
Common Stock
Shares
−991.00
Price / share
$291.71
Trade value
$289.09K
% of position
Common Stock
Shares
−409.00
Price / share
$292.82
Trade value
$119.76K
% of position
Net shares
+0.00
Net value
-$1.18M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | M · Option Exercise | +5K | $52.27 | $261.35K | 12.0% | 41.51K | 46.51K |
| Common Stock Direct | 8/3/2026 | S · Sale | −105.00 | $284.14 | $29.83K | 0.2% | 46.51K | 46.41K |
| Common Stock Direct | 8/3/2026 | S · Sale | −33.00 | $284.55 | $9.39K | 0.1% | 46.41K | 46.38K |
| Common Stock Direct | 8/3/2026 | S · Sale | −157.00 | $285.74 | $44.86K | 0.3% | 46.38K | 46.22K |
| Common Stock Direct | 8/3/2026 | S · Sale | −1.03K | $286.80 | $295.97K | 2.2% | 46.22K | 45.19K |
| Common Stock Direct | 8/3/2026 | S · Sale | −1.21K | $287.77 | $349.36K | 2.7% | 45.19K | 43.97K |
| Common Stock Direct | 8/3/2026 | S · Sale | −356.00 | $288.75 | $102.79K | 0.8% | 43.97K | 43.62K |
| Common Stock Direct | 8/3/2026 | S · Sale | −503.00 | $289.80 | $145.77K | 1.2% | 43.62K | 43.11K |
| Common Stock Direct | 8/3/2026 | S · Sale | −200.00 | $290.60 | $58.12K | 0.5% | 43.11K | 42.91K |
| Common Stock Direct | 8/3/2026 | S · Sale | −991.00 | $291.71 | $289.09K | 2.3% | 42.91K | 41.92K |
| Common Stock Direct | 8/3/2026 | S · Sale | −409.00 | $292.82 | $119.76K | 1.0% | 41.92K | 41.51K |
| Total | +0.00 | -$1.18M | ||||||
Employee Stock Option (right to buy)
Common Stock
5K shares
Shares
−5K
Strike price
52.27
Held after
29.44K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock5K shares | 8/3/2026 | M · Option Exercise | −5K | 52.27 | — | 29.44K |